Nuts and Bolts Sessions

Back by popular demand! Once again, the SNMMI Annual Meeting will offer "Nuts and Bolts” sessions in a wide variety of sub-specialty areas–giving you practical information you can use immediately when you return to work. Here's a sample of nuts and bolts sessions available to you as an Annual Meeting attendee:

Saturday, June 11 | 1:30–3:00 pm PDT
CE03: Will You Be My Mentor? Promoting Inclusive and Equitable Mentorship, Sponsorship, and Coaching in Nuclear Medicine
Sponsored SNMMI In-Training Committee
The CE session will focus on inclusive and equitable mentorship, sponsorship, and coaching in Nuclear Medicine. The speakers will compare mentorship, sponsorship, and coaching in terms of the goals and expectations of the respective relationships. The speakers will discuss the ways to establish effective mentorship and sponsorship relationships. Effective and ineffective mentoring and sponsoring relationships will be presented from the mentee and mentor perspective. Cross-cultural mentorship will be presented to increase diversity and inclusion in Nuclear Medicine.

Saturday, June 11 | 3:15–4:45 pm PDT
CE08: Prostate Cancer Diagnosis and Management: Understanding the Clinician and Patient Perspectives
Sponsored by the SNMMI Committee on Outreach
With recent advances and new approvals in precision imaging and therapies for patients with prostate cancer, nuclear medicine physicians and technologists should understand how information is being transferred to patients, in the clinic, and as outreach. In this session, we will discuss the role of molecular imaging in evaluating and managing prostate cancer in a multidisciplinary approach, including the perspectives of referring physicians and patients. You will hear a prostate cancer survivor share his personal experience with molecular imaging, including the parts of the process he found most helpful vs. those that could have been improved. This will be followed by presentations and discussion from a nuclear medicine imager and a referring physician.

Saturday, June 11 | 3:15–4:45 pm PDT
CE10: Nuts and Bolts – Dosimetry and Case Studies
Sponsored by the SNMMI Dosimetry Task Force
This nuts-and-bolts session sponsored by the Dosimetry Task Force will present 3 cases of studies you may encounter in the clinic: Iodine-131, iobenguane I-131 (Azedra), and Lu-177 dotatate (Lutathera). For each agent, a physician and physicist team will present a patient case including the role of dosimetry in the case. The session will conclude with a lively debate on the pros and cons of personalized dosimetry. This session will be informative for physician, physicists, and technologists and anyone interested in
personalized radiopharmaceutical therapy.

Sunday, June 12 | 12:30–2:00 pm PDT
CE11: Cardiovascular Boot Camp
Sponsored by the SNMMI Cardiovascular Council
This session will introduce participants to key concepts and practice points in clinical nuclear cardiology and highlight the recent updates in practice guidelines. Leaders in the field will educate participants on the various stress protocols and minimizing radiation exposure during SPECT imaging. Key concepts in reporting SPECT myocardial perfusion imaging will be discussed.

Monday, June 13 | 10:00–11:30 am PDT
CE28: Implementing Newly FDA-Approved PET/CT Imaging Agents
Sponsored by the SNMMI Clinical Trials Network
2020 and 2021 have been big years for the field of nuclear medicine and molecular imaging. This session will review the indications, mechanisms of action, and biodistribution of three PET/CT imaging agents (18F-FES, 64Cu-DOTATATE, and 18F-DCFPyL) that were recently approved as well as review case studies to guide nuclear medicine physicians on how to interpret their PET/CT scans.

Monday, June 13| 10:00–11:30 am PDT
CE29:  SPECT Imaging with CZT
Sponsored by the SNMMI Physics, Instrumentation and Data Sciences Council
Since Hal Anger first gave us the gamma camera, we have been using detectors based on NaI crystals and photomultiplier tubes. However, for more than a decade now, there have been commercial camera systems available based on a solid-state technology: the cadmium zinc telluride detectors. These new detectors provide increased energy resolution and have led to new camera designs that provide increased sensitivity and spatial resolution. While the first cameras based on CZT focused on SPECT-only cardiac imaging, new models are now available that provide whole-body and SPECT/CT imaging capability. This session will discuss the fundamentals of how the CZT detectors work and their application in cardiac and whole-body imaging.

Monday, June 13 | 1:00–2:30 pm PDT
CE35: Best Practices to Support Research PET Tracer Production
Sponsored by the SNMMI Radiopharmaceutical Sciences Council
The purpose of the session is to educate attendees on the requirements and expectations for best practices associated with production of research PET tracers. We will provide an avenue for the dissemination of specifics for compliance to USP <823> during research radiotracer preparation, pointers, and details for the preparation of Investigational New Drug (IND) applications, and share a
bench to bedside story of the issues; including steps involved to complete appropriate experiments & documentation for a first-in-man research PET tracer. The target audience consists of scientists, chemists, and pharmacists involved in the development, production, and quality assurance of PET radiotracers for research; as well as investigators interested in clinical translation of novel

Tuesday, June 14 | 10:00–11:30 am PDT
CE46: Brain Imaging Read with the Experts – Nuts and Bolts
Sponsored by the SNMMI Brain Imaging Council
This session will highlight the successes and pitfalls of neuroimaging techniques such as FDG, FDOPA, amyloid and tau PET and PET/MR imaging and DaT SPECT imaging. Cases will be presented where the audience participation, followed by a dissection of the findings, providing insight into the technique or it can be translated to clinical practice.

Tuesday, June 14 | 10:00–11:30 am PDT
CE47: Nuts and Bolts – Radioligand Therapy
Sponsored by the SNMMI Therapy Center of Excellence
This session will discuss and give overview of practical aspects of radioligand therapy especially focus of 177- Lu PSMA in anticipation of increased patient treatments if approved by FDA, preparing for these treatments, management, workflow, reimbursement, and technical aspects. The talks will include perspectives from MD, physicist- imaging and reimbursement and technologist.

Tuesday, June 14 | 10:00–11:30 am PDT
CE50: Production and Radiopharmaceutical Quality Control Considerations for Actinium Therapies
Sponsored by CMIIT
This session will discuss the different routes of production of Ac-225 and what needs to be considered to use in a clinical setting. Including quality control testing and release criteria.